On Apr. 29, 2025, BioMADE announced Maple Grove as the Minnesota site in its national network of bioindustrial manufacturing infrastructure. The facility will further establish the U.S. as a leader in biotechnology and biomanufacturing, support national security initiatives, boost economic opportunity, increase markets for farmers, and bring well-paying manufacturing jobs to the region. 

Located at 7500 Meridian Circle North, the 122,000 square foot facility will feature demonstration-scale piloting equipment, with two 25,000-liter industrial fermenters, allowing innovative companies of all sizes to take their processes to the next level as they march toward full-scale commercial manufacturing.

The project represents an investment of at least $132 million, with funding provided by the U.S. Department of Defense and the Minnesota Department of Employment and Economic Development.